Reuters logo
BRIEF-Kala Pharmaceuticals reports Q3 loss per share $0.56
November 7, 2017 / 12:43 PM / in a month

BRIEF-Kala Pharmaceuticals reports Q3 loss per share $0.56

Nov 7 (Reuters) - Kala Pharmaceuticals Inc

* Kala Pharmaceuticals reports third quarter 2017 financial results and provides business update

* Q3 loss per share $0.56

* Kala Pharmaceuticals - ‍Top-line results from phase 3 clinical program for KPI-121 0.25% in patients with dry eye disease are expected by end of 2017​

* Kala Pharmaceuticals Inc - ‍Expects that its existing cash on hand will enable it to fund operations through Q2 of 2019​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below